Resultados de la búsqueda 121-130 of 13936 for Hepatic encephalopathy

1. Mayo Clinic Digestive Diseases Physician Update - September 2023

   Page 1.

2. Hematología - Ensayos clínicos - Mayo Clinic

   The purpose of this study is to assess the presence of various molecular markers in histiocytic disorders. In addition to this, to review clinical records of ...

3. Hematología - Ensayos clínicos - Mayo Clinic

   All study subjects will receive acalabrutinib, durvalumab, and venetoclax. Acalabrutinib is FDA approved for treatment of chronic lymphocytic leukemia and small ...

4. Mayo Clinic Physician Update - August 2025

   Page 1.

5. Hematología - Ensayos clínicos - Mayo Clinic

   Acalabrutinib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Monoclonal antibodies, such as obinutuzumab, may ...

6. Mayo Clinic Digestive Diseases Physician Update - November 2023

   Page 1.

7. Ensayos clínicos - Centro Pediátrico de Mayo Clinic - Centro Pediátrico de Mayo Clinic

   90 genes related to Monogenic Stone Disease will be determined via DNA analysis by the Mayo Rare Kidney Stone Consortium (RKSC) research staff. Dabrafenib ...

8. Mayo Clinic Cardiovascular Physician Update - May 2024

   Page 1.

9. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   Lymphoma is a diversified disease with outcomes differing upon the types and subtypes of lymphoma as well as treatment modalities used. Fertility outcomes in ...

10. Hematología - Ensayos clínicos - Mayo Clinic

    This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic Leukemia ...